Lifecore Biomedical, Inc. LFCR
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.04M | 17.24M | 20.80M | 18.86M | 18.86M |
| Total Receivables | 31.35M | 38.02M | 26.89M | 29.13M | 29.13M |
| Inventory | 27.70M | 25.48M | 28.16M | 33.80M | 33.80M |
| Prepaid Expenses | 2.60M | 2.95M | 1.80M | 2.14M | 2.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 84.68M | 83.69M | 77.64M | 83.93M | 83.93M |
|
|
|||||
| Total Current Assets | 84.68M | 83.69M | 77.64M | 83.93M | 83.93M |
| Net Property, Plant & Equipment | 122.04M | 123.71M | 125.51M | 123.63M | 123.63M |
| Long-term Investments | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M |
| Goodwill | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M |
| Total Other Intangibles | -- | -- | -- | 4.20M | 4.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.70M | 8.21M | 8.47M | 9.56M | 9.56M |
| Total Assets | 228.30M | 229.50M | 225.50M | 235.20M | 235.20M |
|
|
|||||
| Total Accounts Payable | 8.20M | 7.16M | 6.64M | 10.12M | 10.12M |
| Total Accrued Expenses | 6.95M | 5.94M | 5.09M | 4.16M | 4.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.36M | 1.35M | 1.34M | 1.32M | 1.32M |
| Total Finance Division Other Current Liabilities | 5.53M | 7.19M | 7.43M | 14.37M | 14.37M |
| Total Other Current Liabilities | 5.53M | 7.19M | 7.43M | 14.37M | 14.37M |
| Total Current Liabilities | 22.04M | 21.64M | 20.50M | 29.96M | 29.96M |
|
|
|||||
| Total Current Liabilities | 22.04M | 21.64M | 20.50M | 29.96M | 29.96M |
| Long-Term Debt | 149.23M | 143.10M | 136.53M | 123.27M | 123.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.58M | 11.93M | 12.27M | 12.95M | 12.95M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 67.72M | 36.74M | 35.42M | 32.24M | 32.24M |
| Total Liabilities | 250.58M | 213.41M | 204.72M | 198.42M | 198.42M |
|
|
|||||
| Common Stock & APIC | 211.02M | 210.24M | 209.74M | 207.56M | 207.56M |
| Retained Earnings | -284.42M | -244.34M | -238.18M | -218.10M | -218.10M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -73.40M | -34.09M | -28.44M | -10.54M | -10.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 51.13M | 50.19M | 49.22M | 47.32M | 47.32M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 51.13M | 50.19M | 49.22M | 47.32M | 47.32M |
|
|
|||||
| Total Common Equity | -73.40M | -34.09M | -28.44M | -10.54M | -10.54M |
| Total Preferred Equity | 51.13M | 50.19M | 49.22M | 47.32M | 47.32M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.28M | 16.09M | 20.78M | 36.79M | 36.79M |
|
|
|||||